Published 2 years ago

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Summary by Ground News

Moderna sought emergency use authorization from the FDA on Thursday. An advisory panel of experts to the U.S. drug regulator will meet in June to review the request. Pfizer Inc also expects to have its vaccine data for children under 6 ready by the June review. Moderna's vaccine is approved by the FDA for use in adults 18 and older.

0 Articles

All

Left

Center

Right

Reuters

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Moderna Inc's chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June.

2 years ago·United Kingdom

Read Full Article

Global News

Moderna says COVID-19 vaccine for kids under 6 will be ready for U.S. review in June - National | Globalnews.ca

Moderna's COVID-19 vaccine could be the first to win U.S. approval for children under the age of 5. Pfizer also expects to have its vaccine data for children under 6 ready soon.

2 years ago·Toronto, Canada

Read Full Article

South China Morning Post

Moderna says vaccine for ages under 6 ready for US review in June

Moderna’s vaccine could be the first to win US approval for children under the age of six. Pfizer also expects to have its vaccine data for children under six ready by the June review.

2 years ago·Hong Kong

Read Full Article

CNBC

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Moderna's chief medical officer said the company's vaccine for children under 6 years old will be ready for review by an FDA panel when it meets in June.

2 years ago·United States

Read Full Article

IBTimes

Moderna Says Its Vaccine For Ages Under 6 Will Be Ready For U.S. Review In June

Moderna Inc's chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June.

2 years ago·United States

Read Full Article

Financial Post

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

WASHINGTON -- Moderna Inc's chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June. Read More

2 years ago·Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.